Package 0173-0873-06

{"route": ["ORAL"], "spl_id": "44e97b9b-e22d-4bef-a025-20e71b0b3966", "openfda": {"unii": ["7AN603V4JV"], "rxcui": ["1539251", "1539885", "1596444", "1596445"], "spl_set_id": ["dbb64747-1505-49d7-9a33-99dd402e96d3"], "manufacturer_name": ["GlaxoSmithKline LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TRAY in 1 CARTON (0173-0873-06)  / 1 INHALER in 1 TRAY / 7 AEROSOL, POWDER in 1 INHALER", "package_ndc": "0173-0873-06", "marketing_start_date": "20140430"}, {"sample": false, "description": "1 TRAY in 1 CARTON (0173-0873-10)  / 1 INHALER in 1 TRAY / 30 AEROSOL, POWDER in 1 INHALER", "package_ndc": "0173-0873-10", "marketing_start_date": "20140430"}], "brand_name": "Incruse Ellipta", "product_id": "0173-0873_44e97b9b-e22d-4bef-a025-20e71b0b3966", "dosage_form": "AEROSOL, POWDER", "pharm_class": ["Anticholinergic [EPC]", "Cholinergic Antagonists [MoA]"], "product_ndc": "0173-0873", "generic_name": "umeclidinium", "labeler_name": "GlaxoSmithKline LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Incruse Ellipta", "active_ingredients": [{"name": "UMECLIDINIUM BROMIDE", "strength": "62.5 ug/1"}], "application_number": "NDA205382", "marketing_category": "NDA", "marketing_start_date": "20140430", "listing_expiration_date": "20261231"}